Home     About SABCS     Press Releases     Media     Event Photos     Past Symposia     Satellite Symposia     Patient Advocates     FAQs     Contact Us



Call for Abstracts           Registration           Hotel           Support & Exhibits     2014 Overview           Program           Travel & Transportation          

Quick Links
 

 
 
 

Program Schedule 2014   >  Preliminary Program

h
Spacer
PRELIMINARY PROGRAM
Working titles/topics shown.  Final titles and speakers will follow.
Spacer

Tuesday, December 9, 2014

 
Spacer

EDUCATIONAL SESSIONS

Most of the presentations at SABCS focus on the latest clinical and basic research results relating to breast cancer. By contrast, educational sessions are designed to inform and update those interested in a review on a particular topic. Although these sessions may include new specific research findings, their primary intent is to offer summaries of existing knowledge, and to provide background for some of the active areas which will be discussed in the rest of the meeting.

   
 

Breast Cancer on a Global Scale: From Biology to Treatment Outcome

Moderator: Melissa Bondy, PhD

Baylor College of Medicine

Houston, TX

 

Global patterns of breast cancer

Benjamin Anderson, MD

University of Washington and Fred Hutchinson Cancer Center - Breast Health Global Initiative

Seattle, WA

 

The biology in breast cancer health disparities

Patricia Thompson, PhD

University of Arizona Cancer Center

Tucson, AZ

 

Breast cancer in developing countries - challenges and opportunities

Hamdy A. Azim, MSc, MD

Cairo University

Cairo, EGYPT

 

Breast Cancer Survivorship: One Size Does Not Fit All

Moderator: Polly Niravath, MD

Baylor College of Medicine

Houston, TX

 

Aromatase inhibitor compliance

Norah Lynn Henry, MD, PhD

University of Michigan

Ann Arbor, MI

 

Second primary cancers among breast cancer survivors

Christopher I. Li, MD, PhD

Fred Hutchinson Cancer Research Center

Seattle, WA

 

Disparate needs of minority breast cancer survivors

Kimlin Tam Ashing, PhD

City of Hope Medical Center

Duarte, CA

 

HER2 Positive Breast Cancer: Insights From the Lab and Clinic

Moderator: Mothaffar Rimawi, MD

Baylor College of Medicine

Houston, TX

 

HER2 signaling and how it drives tumor growth and some mechanisms of resistance

Mark M. Moasser, MD

University of California

San Francisco, CA

 

Neoadjuvant therapy in HER2 positive breast cancer, latest developments and biomarkers and how it serves as a discovery platform

Sibylle Loibl, MD, PhD

German Breast Group

Neu-Isenburg, GERMANY

 

Management of metastatic HER2 positive disease, how to use available agents and an overview of new products in development

Ian Krop, MD, PhD

Dana-Farber Cancer Institute

Boston, MA

 

Introduction to Immunotherapy

Moderator: Douglas Yee, MD

University of Minnesota

Minneapolis, MN

 

Immunotherapeutic approaches to breast cancer

Mary L. (Nora) Disis, MD

University of Washington

Seattle, WA

 

Immune checkpoints and cancer therapy

Jeffrey S. Weber, MD, PhD

Moffitt Cancer Center

Tampa, FL

 

Tumor infiltrating lymphocytes in breast cancer

Sherene Loi, MBBS (Hons), FRACP, PhD

Peter MacCallum Cancer Centre

Melbourne, AUSTRALIA

 

Molecular Heterogeneity

Moderator: Andrea L. Richardson, MD, PhD

Dana-Farber Cancer Institute

Boston, MA

 

Tumor heterogeneity and sub clonal structure as revealed by NGS

Lucy Yates, MD

Cambridge Institute for Medical Research

Cambridge, UNITED KINGDOM

 

The principles of circulating tumor DNA

Ben Ho Park, MD, PhD

The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Baltimore, MD

 

Cancer plasticity and epigenetic heterogeneity

Kornelia Polyak, MD, PhD

Dana-Farber Cancer Institute

Boston, MA

 

Neoadjuvant Treatment of ER+ Breast Cancer

Moderator: Professor Mitchell Dowsett

Royal Marsden Hospital

London, UNITED KINGDOM

 

Clinical insights on the neoadjuvant therapy of ER+ breast cancer

David Cameron, MD

Edinburgh Research Cancer Centre

Edinburgh, UNITED KINGDOM

 

Biomarkers for clinical management and research

Professor Mitchell Dowsett

Royal Marsden Hospital

London, UNITED KINGDOM

 

The integration of novel targeted agents with endocrine therapy

Ingrid A. Mayer, MD, MSCI

Vanderbilt University School of Medicine

Nashville, TN

 

New Insights in Breast Radiation

Moderator: Richard L. Crownover, MD, PhD

UT Health Science Center

San Antonio, TX

 

TBD

Professor Ian Kunkler

Western General Hospital

Edinburgh, UNITED KINGDOM

 

TBD

Professor Ivo Olivotto

University of Calgary and Tom Baker Cancer Centre

Calgary, CANADA

 

TBD

Professor John Yarnold

Royal Marsden and Institute of Cancer Research

London, UNITED KINGDOM

 

Optimizing Clinical Outcomes and Quality of Life in Breast Reconstruction

Moderator: John Benson, MD

Cambridge University Hospitals NHS Foundation Trust

Cambridge, UNITED KINGDOM

 

The impact of patient perspective on outcomes in breast reconstruction

Andrea L. Pusic, MD, MHS

Memorial Sloan-Kettering Cancer Center

New York, NY

 

Reconstruction for the high risk patient: challenges of chemotherapy, radiation therapy and patient selection

Mehra Golshan, MD

Brigham and Women's Hospital

Boston, MA

 

Delayed and immediate partial breast reconstruction after breast conserving surgery

Krishna B. Clough, MD

L 'Institut du Sein-Paris Breast Centre

Paris, FRANCE

 

Triple Negative Breast Cancer

Moderator: Nicholas Turner, PhD, FRCP

Royal Marsden and Institute of Cancer Research

London, UNITED KINGDOM

 

The clinical significance of heterogeneity in triple negative breast cancer

Nicholas Turner, PhD, FRCP

Royal Marsden and Institute of Cancer Research

London, UNITED KINGDOM

 

Therapeutic approaches on the horizon

Andrew Tutt, Dr Med

Kings College London

London, UNITED KINGDOM

 

Adjuvant and neoadjuvant therapy: Current practice and future approaches

Eric P. Winer, MD

Dana-Farber Cancer Institute

Boston, MA

 
Top
Spacer
AWARD LECTURES
Spacer
Exhibit Hall D  
 

William L. McGuire Memorial Lecture

TBD

James N. Ingle, MD

Mayo Clinic

Rochester, MN

   
 

AACR Distinguished Lectureship in Breast Cancer Research

TBD

Mary-Claire King, PhD

University of Washington

Seattle, WA

   
 

AACR Outstanding Investigator Award for Breast Cancer Research, funded by Susan G. Komen®

   
 

Susan G. Komen® Brinker Awards for Scientific Distinction Lectures

 
Top
Spacer
PLENARY LECTURES

 

Spacer
Exhibit Hall D  
 

State of the Art - Endocrine Therapy

Nancy E. Davidson, MD

University of Pittsburgh

Pittsburgh, PA

Genome-Directed Therapeutics for Endocrine Therapy Resistant ER+ Breast Cancer

Matthew J. Ellis, MD, PhD

Washington University School of Medicine

St. Louis, MO

Patient Derived Xenografts - Pre-Clinical Models for Prevention and Treatment of Metastasis

Alana L. Welm, PhD

University of Utah School of Medicine

Salt Lake City, UT

 
Top
Spacer
MINI-SYMPOSIA  
Spacer
Exhibit Hall D  
 

Targeting Epigenetics in Breast Cancer

Moderator: Vered Stearns, MD

John Hopkins University School of Medicine

Baltimore, MD

 

TBD

Peter W. Laird, PhD

University of Southern California

Los Angeles, CA

 

TBD

Vered Stearns, MD

Johns Hopkins Sidney Kimmel Comprehensive Cancer Center

Baltimore, MD

 

Breast Cancer Predisposition: Germline and Risk

Moderator: Laura J. van 't Veer, PhD

University of California

San Francisco, CA

 

Titles and speakers pending

 
Top
Spacer

THE YEAR IN REVIEW

Saturday, December 13, 2014

 
Spacer
Exhibit Hall D  
 

Moderator: C. Kent Osborne, MD

Baylor College of Medicine

Houston, TX

Basic

Charlotte Kuperwasser, PhD

Tufts University School of Medicine

Boston, MA

Translational

Jorge S. Reis-Filho, MD, PHD, FRCPath

Memorial Sloan-Kettering Cancer Center

New York, NY

Adjuvant

Harold J. Burstein, MD, PhD

Dana-Farber Cancer Institute

Boston, MA

Metastatic

William J. Gradishar, MD

Northwestern University Feinberg School of Medicine

Chicago, IL

 
Top
Spacer
BASIC SCIENCE FORUMS

 

Spacer
Ballroom B  
 

Discovering Rational Combination Therapies

Moderator: Carlos Arteaga, MD

Vanderbilt-Ingram Cancer Center

Vanderbilt University

Nashville, TN

 

DNA repair in breast cancer

Alan D'Andrea, MD

Dana-Farber Cancer Institute

Boston, MA

 

shRNA and other novel discovery approaches

René Bernards, PhD

Netherlands Cancer Institute

Amsterdam, NETHERLANDS

 

How Do Mutations Occur in Breast Cancer?

Moderator: Douglas Yee, MD

University of Minnesota

Minneapolis, MN

 

APOBEC3B

Reuben S. Harris, PhD

University of Minnesota

Minneapolis, MN

 

ADARs

Catriona Jamieson, MD, PhD

UCSD Moore Cancer Center

La Jolla, CA

 

New Insights into Metastatic Progression

Moderator: Xiang Zhang, PhD

Baylor College of Medicine

Houston, TX

 

Collective invasion in breast cancer is led by specialized cancer cells with basal gene expression

Andrew Ewald, PhD

Johns Hopkins University School of Medicine

Baltimore, MD

 

Targeting the LIFR-Hippo-YAP pathway as an anti-metastatic strategy

Li Ma, PhD

UT MD Anderson Cancer Center

Houston, TX

 

 
Top
Spacer
CLINICAL SCIENCE FORUM  
Spacer
Ballroom A  
 

Contralateral Prophylactic Mastectomy: Controversies and Trends

Moderator: Ismail Jatoi, MD, PhD, FACS

UT Health Science Center at San Antonio

San Antonio, TX

 

Clinical implications of contralateral prophylactic mastectomy

Ismail Jatoi, MD, PhD, FACS

UT Health Science Center at San Antonio

San Antonio, TX

 

Contralateral prophylactic mastectomy: Patient preferences and risk perceptions

Ann Partridge, MD, MPH

Dana-Farber Cancer Institute

Boston, MA

 

What are the implications for reconstruction following contralateral prophylactic mastectomy?

Andrea L. Pusic, MD, MHS

Memorial Sloan-Kettering Cancer Center

New York, NY

 

 
Top
------------------------------------------------------------------------------------------------------------------------------------------------------------------
SPECIAL FORUM  
-----------------------------------------------------------------------------------------------------------------------------------------------------------------
   
 

Role of Advocates in Legislation, Research and Community Support

Moderator: Susan W. Rafte

Pink Ribbons Project

Houston, TX

 

Jane Perlmutter, PhD, MBA

Gemini Group

Ann Arbor, MI

 

Elizabeth Frank

Dana-Farber Cancer Institute

Boston, MA

 

Valerie Worthy

Duke Cancer Institute

Durham, NC

 

Accelerating International Drug Development, Companion Diagnostics, and Their Approval

Moderator: Laura J. van 't Veer, PhD

University of California

San Franciso, CA

 

Speakers pending

 

 

   
Spacer
CASE DISCUSSIONS  
Spacer
Ballroom A

 

 

Moderator: Mothaffar Rimawi, MD

Baylor College of Medicine

Houston, TX

 
Top
Spacer
CAREER DEVELOPMENT FORUM: A NETWORKING SESSION FOR YOUNG INVESTIGATORS  
Spacer
 

The session is open to early-career scientists, defined as graduate students, postdoctoral or clinical fellows, or medical students and residents, who are registered attendees of the 2014 SABCS. Space in the workshop is limited to 300 participants; registrations will be accepted on a first-come, first-served basis and is free of charge.  You can register for this session when you register for the Symposium.

 
Top
Spacer
PRELIMINARY SCHEDULE
Hours subject to change.
Spacer

Tuesday, December 9

Registration

Program (Educational Sessions)

 

8:00 AM-7:00 PM

12:00 PM-7:00 PM

Wednesday, December 10

Registration

Program (Main Program begins)

Exhibits

 

7:00 AM-5:15 PM

8:00 AM-7:00 PM

11:00 AM-5:00 PM

Thursday, December 11

Registration

Program

Exhibits

 

7:00 AM-5:15 PM

7:30 AM-7:00 PM

11:00 AM-5:00 PM

Friday, December 12

Registration

Program

Exhibits

 

7:00 AM-5:15 PM

7:30 AM-7:00 PM

11:00 AM-5:00 PM

Saturday, December 13

Registration

Program

 

7:00 AM-9:00 AM

7:30 AM-11:00 AM

 
Home | About SABCS | Press Releases | Media | Event Photos | Past Symposia | Satellite Symposia | Patient Advocates | FAQs | Contact Us
Call for Abstracts | Registration | Hotel | Support & Exhibits | 2014 Overview | Program | Travel & Transportation

Rich Markow, Director, Symposia
Cancer Therapy & Research Center at UT Health Science Center San Antonio

7979 Wurzbach Road, MC 8224 San Antonio, TX 78229 USA
Phone: 210-450-1550    Fax: 210-450-1560    Email: sabcs@uthscsa.edu
       line
Copyright 2014 SABCS. All rights reserved. - Privacy Policy